Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Chrystel Isca"'
Autor:
Claudia Omarini, Federico Piacentini, Isabella Sperduti, Monica Barbolini, Chrystel Isca, Angela Toss, Laura Cortesi, Elena Barbieri, Massimo Dominici, Luca Moscetti
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-10 (2020)
Abstract Background Elderly patients are underrepresented in clinical study where combined endocrine strategies were compared to endocrine therapy (ET) in hormone receptors positive, HER2 negative, metastatic breast cancer. The role of the new endocr
Externí odkaz:
https://doaj.org/article/30245269f8334eaebbed057edb937585
Autor:
Claudia Omarini, Stefania Bettelli, Samantha Manfredini, Monica Barbolini, Chrystel Isca, Giulia Cortesi, Antonino Maiorana, Giovanni Tazzioli, Massimo Dominici, Federico Piacentini
Publikováno v:
Translational Oncology, Vol 13, Iss 9, Pp 100794- (2020)
Introduction: In early-stage HER2 positive breast cancer (BC) patients, tumor response to neoadjuvant chemotherapy (NACT) predict survival outcomes. Patients achieving less than pathological complete response (pCR) have a worse prognosis, however, th
Externí odkaz:
https://doaj.org/article/74ac457ff3604c6aad4b57d0160de40e
Autor:
Chrystel Isca, Amelia Spinella, Angela Toss, Marco de Pinto, Guido Ficarra, Luca Fabbiani, Anna Iannone, Luca Magnani, Federica Lumetti, Pierluca Macripò, Caterina Vacchi, Elisa Gasparini, Simonetta Piana, Laura Cortesi, Antonino Maiorana, Carlo Salvarani, Massimo Dominici, Dilia Giuggioli
Publikováno v:
Journal of Personalized Medicine; Volume 12; Issue 12; Pages: 2007
Several authors reported an increased risk of cancer in SSc patients, including breast cancer (BC). Nevertheless, the mechanisms underlying this association have not yet been clarified. SSc and BC share several molecular pathways, which seem to play
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Stefania Crucitta, Andrea Fontana, G. Lorenzini, Claudia Omarini, Lucrezia Diodati, Michela Palleschi, M. Del Re, U. De Giorgi, Romano Danesi, Icro Meattini, Lorenzo Livi, Stefano Fogli, Chrystel Isca, Federico Piacentini
Publikováno v:
ESMO Open
Background Proton-pump-inhibitors (PPIs) are frequently prescribed for the management of anticancer drug-related gastrointestinal symptoms. Palbociclib is a weak base with pH-dependent solubility and potential drug-drug interaction at the absorption
Autor:
Luca Magnani, Carlo Salvarani, Antonino Maiorana, Paola Castrignanò, Anna Iannone, Caterina Vacchi, Luca Fabbiani, Massimo Dominici, Elisa Gasparini, Amelia Spinella, Chrystel Isca, Dilia Giuggioli, Pierluca Macripo, Angela Toss, Simonetta Piana, Laura Cortesi, Guido Ficarra
Publikováno v:
Journal of Personalized Medicine
Journal of Personalized Medicine, Vol 11, Iss 580, p 580 (2021)
Volume 11
Issue 6
Journal of Personalized Medicine, Vol 11, Iss 580, p 580 (2021)
Volume 11
Issue 6
Systemic Sclerosis (SSc) is a chronic disease associated with a 1.5-fold increase in cancer risk, including lung cancer, hematological malignancies, and breast cancer (BC). This is a retrospective study aiming to explore the clinical and pathological
Autor:
Federico Piacentini, Sara Balduzzi, Patrizia Palumbo, Annarita Pecchi, Luca Moscetti, Cecilia Nasso, Claudia Omarini, Monica Barbolini, Stefano Draisci, Giovanni Tazzioli, Stefano Cascinu, Pietro Torricelli, Silvia Galetti, Chrystel Isca, Alessandro Bocconi
Publikováno v:
Cancer Management and Research. 11:9563-9569
Background Fat tissue is strongly involved in BC tumorigenesis inducing insulin resistance, chronic inflammation and hormonal changes. Computed tomography (CT) imaging instead of body mass index (BMI) gives a reliable measure of skeletal muscle mass
Autor:
E Molinaro, Chrystel Isca, Elena Barbieri, Stefano Cascinu, Federico Piacentini, Marta Venturelli, Luca Moscetti, Laura Cortesi, Isabella Sperduti, Claudia Omarini, Angela Toss
Publikováno v:
Cancer Research. 79:P1-18
The standard first-line for endocrine sensitive metastatic breast cancer (BC) is represented by endocrine therapy. Several phase III clinical trials searched for more effective endocrine strategies. Nevertheless, the use of combinations for the first
Autor:
U. De Giorgi, M. Del Re, Federico Piacentini, Sara Bleve, Lorenzo Livi, Lucrezia Diodati, Stefano Fogli, Annalisa Fontana, Chrystel Isca, Michela Palleschi, Romano Danesi, Icro Meattini, Claudia Omarini, Stefania Crucitta, G. Lorenzini
Publikováno v:
Annals of Oncology. 32:S463-S464